RAB25 and head and neck squamous cell carcinoma: Importantly, HNSCC mice showed more sensitivity to docetaxel when pretreated with miR-185-3p inhibitor, and overexpression of RAB25 blunted the effects of miR185-3p, indicating that the increased miR-185-3p promoted drug resistance by targeting RAB25.